Neuraxis, Inc. Files 8-K: Rights, Bylaws, and Financials Updated
Ticker: NRXS · Form: 8-K · Filed: Nov 21, 2024 · CIK: 1933567
| Field | Detail |
|---|---|
| Company | Neuraxis, INC (NRXS) |
| Form Type | 8-K |
| Filed Date | Nov 21, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001, $3.80 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update, financials
TL;DR
Neuraxis 8-K filed: Rights, bylaws, and financials updated. Watch for changes.
AI Summary
Neuraxis, Inc. filed an 8-K on November 21, 2024, reporting events as of November 15, 2024. The filing indicates material modifications to the rights of security holders and amendments to its articles of incorporation or bylaws. It also includes financial statements and exhibits.
Why It Matters
This 8-K filing signals potential changes in the company's corporate structure or security holder rights, which could impact investors' stakes and the company's governance.
Risk Assessment
Risk Level: medium — Material modifications to rights and amendments to bylaws can indicate significant corporate events that may affect stock value and investor confidence.
Key Numbers
- 001-41775 — SEC File Number (Identifies the company's filing with the SEC.)
- 45-5079684 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Neuraxis, Inc. (company) — Registrant
- November 15, 2024 (date) — Earliest event reported date
- November 21, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- 11611 N. Meridian St , Suite 330 Carmel , IN 46032 (address) — Principal executive offices
FAQ
What specific material modifications were made to the rights of security holders?
The filing indicates material modifications to the rights of security holders, but the specific details of these modifications are not provided in the provided text excerpt.
What amendments were made to Neuraxis, Inc.'s articles of incorporation or bylaws?
The filing states that there were amendments to the articles of incorporation or bylaws, but the specific changes are not detailed in the provided text.
What is the significance of the 'Financial Statements and Exhibits' item in this 8-K filing?
This item indicates that financial statements and other exhibits are being filed as part of this report, which could provide updated financial information or supporting documentation for the reported events.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on November 15, 2024.
What is Neuraxis, Inc.'s state of incorporation and principal executive office address?
Neuraxis, Inc. is incorporated in Delaware and its principal executive offices are located at 11611 N. Meridian St , Suite 330 Carmel , IN 46032.
Filing Stats: 615 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2024-11-21 17:17:59
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value NRXS NYSE American Indi
- $3.80 — e on the basis of a conversion price of $3.80. The information set forth herein is
Filing Documents
- form8-k.htm (8-K) — 38KB
- ex3-1.htm (EX-3.1) — 14KB
- 0001493152-24-047196.txt ( ) — 230KB
- nrxs-20241115.xsd (EX-101.SCH) — 3KB
- nrxs-20241115_lab.xml (EX-101.LAB) — 33KB
- nrxs-20241115_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 21, 2024 NEURAXIS, INC. By: /s/ Brian Carrico Name: Brian Carrico Title: President and Chief Executive Officer